Sudden bilateral corneal oedema in a patient with Parkinson's disease

Acta Ophthalmologica

Volumn 89, Issue 2, 2011, Pages 198-199

  Park, Choul Yong ^a   Chuck, Roy S ^b  

^a Dongguk University College of Medicine   (South Korea)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE SULFATE;

ADULT; ARTICLE; CASE REPORT; CORNEA EDEMA; DRUG WITHDRAWAL; HUMAN; INTRAOCULAR PRESSURE; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RETINOSCOPY; SLIT LAMP; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AMANTADINE; ANTIPARKINSON AGENTS; BLINDNESS; CORNEAL EDEMA; FUNCTIONAL LATERALITY; HUMANS; MALE; PARKINSON DISEASE; VISUAL ACUITY;

EID: 79952216563     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01561.x     Document Type: Article

References (5)

1. Chang KC, Kim MK, Wee WR & Lee JH (2008): Corneal endothelial dysfunction associated with amantadine toxicity. Cornea 27: 1182-1185.
2. Crosby N, Deane KH & Clarke CE (2003): Amantadine in Parkinson's disease. Cochrane Database Syst Rev CD003468.
3. French DD & Margo CE (2007): Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. Cornea 26: 1087-1089.
4. Jeng BH, Galor A, Lee MS, Meisler DM, Hollyfield JG, Schoenfield L, McMahon JT & Langston RH (2008): Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology 115: 1540-1544.
5. Kubo S, Iwatake A, Ebihara N, Murakami A & Hattori N (2008): Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature. Parkinsonism Relat Disord 14: 166-169. (Pubitemid 351726302)